Literature DB >> 20607462

Rubbing salt into wounds: hypertonic saline to assist with volume removal in heart failure.

Mark Liszkowski1, Anju Nohria.   

Abstract

Traditionally accepted management strategies for patients with heart failure include sodium and fluid restriction, neurohormonal blockade, and the use of loop diuretics to achieve and maintain euvolemia. Despite continued advances in medical and device therapy, fluid management remains a significant problem in patients with the cardiorenal syndrome (manifested as diuretic resistance and worsening renal function with more aggressive attempts at volume removal). This article examines the counterintuitive use of hypertonic saline as a potential therapy to facilitate diuresis in patients with decompensated heart failure and diuretic resistance. Low-volume hypertonic saline administration offsets counterproductive neurohormonal upregulation, transiently improves hemodynamics, and promotes renal sodium excretion with accompanied net water loss and preservation of renal function. This "new" therapeutic tool should be explored further as an adjunct to current medical therapies in the management of patients with refractory volume overload.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20607462     DOI: 10.1007/s11897-010-0018-4

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  41 in total

1.  Diuretic therapy and resistance in congestive heart failure.

Authors:  D H Ellison
Journal:  Cardiology       Date:  2001       Impact factor: 1.869

2.  Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.

Authors:  S Paterna; P Di Pasquale; G Parrinello; P Amato; A Cardinale; G Follone; A Giubilato; G Licata
Journal:  Eur J Heart Fail       Date:  2000-09       Impact factor: 15.534

3.  Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Authors:  Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

4.  Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.

Authors:  Salvatore Paterna; Pietro Di Pasquale; Gaspare Parrinello; Ersilia Fornaciari; Francesca Di Gaudio; Sergio Fasullo; Marco Giammanco; Filippo M Sarullo; Giuseppe Licata
Journal:  J Am Coll Cardiol       Date:  2005-06-21       Impact factor: 24.094

5.  Effect of hypertonic saline infusion on renal vascular resistance in anesthetized dogs.

Authors:  T Fujita; Y Matsuda; T Shibamoto; H Uematsu; F Sawano; S Koyama
Journal:  Jpn J Physiol       Date:  1991

6.  The cardiorenal syndrome: do we need a change of strategy or a change of tactics?

Authors:  Mariell Jessup; Maria Rosa Costanzo
Journal:  J Am Coll Cardiol       Date:  2009-02-17       Impact factor: 24.094

7.  2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation.

Authors:  Sharon Ann Hunt; William T Abraham; Marshall H Chin; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Mariell Jessup; Marvin A Konstam; Donna M Mancini; Keith Michl; John A Oates; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2009-04-14       Impact factor: 24.094

8.  Changes in natriuretic peptide and cytokine plasma levels in patients with heart failure, after treatment with high dose of furosemide plus hypertonic saline solution (HSS) and after a saline loading.

Authors:  A Tuttolomondo; A Pinto; D Di Raimondo; S Corrao; R Di Sciacca; R Scaglione; C Caruso; G Licata
Journal:  Nutr Metab Cardiovasc Dis       Date:  2010-03-25       Impact factor: 4.222

9.  Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function).

Authors:  Adriaan A Voors; Howard C Dittrich; Barry M Massie; Paul DeLucca; George A Mansoor; Marco Metra; Gad Cotter; Beth D Weatherley; Piotr Ponikowski; John R Teerlink; John G F Cleland; Christopher M O'Connor; Michael M Givertz
Journal:  J Am Coll Cardiol       Date:  2011-05-10       Impact factor: 24.094

10.  Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).

Authors:  Liviu Klein; Barry M Massie; Jeffrey D Leimberger; Christopher M O'Connor; Ileana L Piña; Kirkwood F Adams; Robert M Califf; Mihai Gheorghiade
Journal:  Circ Heart Fail       Date:  2008-05       Impact factor: 8.790

View more
  8 in total

Review 1.  Retroelements and formation of chimeric retrogenes.

Authors:  A A Buzdin
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

Review 2.  Hypertonic saline plus i.v. furosemide improve renal safety profile and clinical outcomes in acute decompensated heart failure: A meta-analysis of the literature.

Authors:  R De Vecchis; C Esposito; C Ariano; S Cantatrione
Journal:  Herz       Date:  2014-03-30       Impact factor: 1.443

3.  Salt and water imbalance in chronic heart failure.

Authors:  Gaspare Parrinello; Daniele Torres; Salvatore Paterna
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

Review 4.  The Effects of Exercise-Based Interventions on Fluid Overload Symptoms in Patients with Heart Failure: A Systematic Review and Meta-Analysis.

Authors:  Mei Rosemary Fu; Yuan Li; Catherine Conway; Alessandra Masone; Jinbo Fang; Christopher Lee
Journal:  Biomedicines       Date:  2022-05-11

Review 5.  Renal dysfunction in acute congestive heart failure: a common problem for cardiologists and nephrologists.

Authors:  Giorgio Graziani; Daniela Pini; Silvia Oldani; David Cucchiari; Manuel Alfredo Podestà; Salvatore Badalamenti
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

6.  Induction of renal tumor necrosis factor-α and other autacoids and the beneficial effects of hypertonic saline in acute decompensated heart failure.

Authors:  Stergios Gatzoflias; Shoujin Hao; Nicholas R Ferreri
Journal:  Am J Physiol Renal Physiol       Date:  2021-05-10

7.  Effects of hypertonic saline solution on body weight and serum creatinine in patients with acute decompensated heart failure.

Authors:  Gabrielle Lafrenière; Patrick Béliveau; Jean-Yves Bégin; David Simonyan; Sylvain Côté; Valérie Gaudreault; Zeev Israeli; Shahar Lavi; Rodrigo Bagur
Journal:  World J Cardiol       Date:  2017-08-26

8.  Hypertonic saline for fluid resuscitation after cardiac surgery (HERACLES): study protocol for a preliminary randomised controlled clinical trial.

Authors:  Carmen A Pfortmueller; Anna S Messmer; Benjamin Hess; David Reineke; Laura Jakob; Stefanie Wenger; Jan Waskowski; Patrick Zuercher; Frederik Stoehr; Gabor Erdoes; Markus M Luedi; Stephan M Jakob; Lars Englberger; Joerg C Schefold
Journal:  Trials       Date:  2019-06-14       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.